Welcome to our dedicated page for ASTERA LABS SEC filings (Ticker: ALAB), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Astera Labs, Inc. SEC filings page for ticker ALAB provides access to the company’s official regulatory disclosures as filed with the U.S. Securities and Exchange Commission. As a Nasdaq-listed semiconductor company focused on rack-scale AI infrastructure, Astera Labs uses these filings to report material events, financial results, and other information relevant to investors.
Recent filings include multiple Form 8-K reports. Some of these 8-Ks furnish press releases covering quarterly financial results, described under Item 2.02, “Results of Operations and Financial Condition.” Others report material events such as Astera Labs entering into a definitive agreement to acquire aiXscale Photonics GmbH, disclosed under Item 8.01, “Other Events.” These documents link directly to the company’s public communications and provide the formal regulatory record.
Through this page, users can locate Astera Labs’ quarterly earnings information as furnished in Form 8-K, along with other current reports that explain significant developments in the business. While the examples provided reference 8-K filings, the broader filings history may also include annual reports on Form 10-K, quarterly reports on Form 10-Q, and other forms that detail the company’s financial condition, risk factors, and governance matters.
Stock Titan enhances these filings with AI-powered summaries that help explain key points from lengthy documents, such as earnings releases or transaction announcements. Real-time updates from EDGAR allow investors to see new ALAB filings as they appear, while AI-generated highlights can make it easier to understand how specific disclosures relate to Astera Labs’ rack-scale AI connectivity strategy, collaborations with hyperscalers, and acquisitions such as the aiXscale Photonics agreement.
Astera Labs CEO Jitendra Mohan executed planned sales of common stock on June 20, 2025, through a pre-established Rule 10b5-1 trading plan from December 2024. The transactions involved the sale of approximately 52,743 shares at weighted average prices ranging from $100.00 to $101.73 per share.
The sales were distributed across multiple trusts:
- Living Trust: 8,790 shares (remaining: 4,342,220 shares)
- Trust: 8,793 shares (remaining: 762,210 shares)
- 2021 Trust 1 & 2: 8,790 shares each (remaining: 762,217 shares each)
- 2022 Trust 1 & 2: 8,790 shares each (remaining: 512,218 shares each)
Mohan maintains direct ownership of 2,262,318 shares and serves as both Director and CEO. The filing includes standard disclaimers regarding beneficial ownership of trust-held securities.
Director Manuel Alba of Astera Labs (ALAB) reported multiple stock sales executed on June 20, 2025, through a pre-established Rule 10b5-1 trading plan from May 2024. The transactions involved:
- Casa Alameda 2007 LLC sold 3,709 shares at weighted average prices between $100.63-101.25 per share
- Alba Trust disposed of 16,441 shares at similar price ranges of $100.63-101.25 per share
Following these transactions, Alba maintains beneficial ownership of: 432,854 shares through Casa Alameda LLC, 1,967,757 shares via Alba Trust, 5,000 shares through spouse, and 2,351 shares directly. The filing includes disclaimers regarding beneficial ownership of trust and LLC holdings, limiting claims to Alba's pecuniary interests. All sales were executed according to the automated trading plan, demonstrating planned portfolio management rather than reactive selling.
A Form 144 filing for Astera Labs indicates a proposed sale of 686 shares of common stock with an aggregate market value of $60,368. The sale is planned to be executed through UBS Financial Services on the NASDAQ exchange, with an approximate sale date of June 24, 2025.
The shares were acquired on June 23, 2025, through a Restricted Stock Unit (RSU) grant from the issuer. The current total shares outstanding for the company is 164,916,814.
Key details:
- Share price implied by filing: ~$88 per share
- Transaction represents approximately 0.0004% of total shares outstanding
- No other securities were sold by the filer during the past 3 months
- Sale will be executed on NASDAQ through UBS Financial Services
Astera Labs President and COO Sanjay Gajendra executed multiple stock sales on June 18, 2025, through a pre-planned Rule 10b5-1 trading arrangement established on November 30, 2024. The transactions included:
- 52,933 shares sold at weighted average price of $98.3779
- 4,926 shares sold at weighted average price of $99.2065
- Two separate sales of 9,257 shares each at approximately $98.19 per share
Following these transactions, Gajendra's beneficial ownership stands at:
- 2,262,318 shares held directly
- 5,930,545 shares in Trust 1
- 715,000 shares each in Trust 2 and Trust 3
The sales were executed automatically under the trading plan, demonstrating structured portfolio management by the insider. Gajendra maintains significant ownership through both direct holdings and trust arrangements, while disclaiming beneficial ownership of trust-held shares except for his pecuniary interest.
Jitendra Mohan, Chief Executive Officer and Director of Astera Labs (ALAB), reported multiple sales of common stock on June 17, 2025, executed through a pre-established Rule 10b5-1 trading plan from December 2, 2024.
The transactions involved the sale of 106,510 total shares at a weighted average price of $94.5417 per share across six different trusts. The sales were executed in multiple tranches with prices ranging from $93.36 to $96.78 per share.
Following the transactions, Mohan's holdings are distributed as follows:
- Direct ownership: 2,262,318 shares
- Indirect ownership through various trusts: - Living Trust: 4,351,010 shares - Trust: 771,003 shares - 2021 Trusts: 1,542,014 shares combined - 2022 Trusts: 1,042,016 shares combined
The filing indicates Mohan disclaims beneficial ownership of the trust-held securities except for his pecuniary interest.
Astera Labs, Inc. (ALAB) filed a Form S-8 on 18 June 2025 to register 9,721,048 additional shares of common stock for issuance under two employee equity programs:
- 2024 Stock Option & Incentive Plan: 8,100,874 shares
- 2024 Employee Stock Purchase Plan: 1,620,174 shares